RAPT Therapeutics(RAPT) - 2024 Q3 - Quarterly Results

Exhibit 99.1 RAPT Therapeutics Reports Third Quarter 2024 Financial Results SOUTH SAN FRANCISCO, Calif. – November 12, 2024 – RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today reported financial results for the third quarter and nine months ended September 30, 2024. Financial Results for the T ...